Preparing to introduce the varicella vaccine into the Italian immunisation programme: Varicella-related hospitalisations in Tuscany, 2004-2012

Eurosurveillance

Volumn 21, Issue 24, 2016, Pages

  Boccalini, S ^a   Bonanni, Paolo ^a   Bechini, A ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX MEASLES MUMPS RUBELLA VACCINE; CHICKENPOX VACCINE; MEASLES MUMPS RUBELLA VACCINE;

ADOLESCENT; ADULT; AGE; ARTICLE; CHILD; HEALTH PROGRAM; HOSPITAL COST; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; ICD-9-CM; IMMUNIZATION; INFANT; ITALY; LENGTH OF STAY; MEDICAL RECORD; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; RISK FACTOR; RISK REDUCTION; SCHOOL CHILD; VACCINATION; YOUNG ADULT; CHICKENPOX; FEMALE; INCIDENCE; MALE; MASS IMMUNIZATION; PREVENTIVE HEALTH SERVICE; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

CHICKENPOX; CHICKENPOX VACCINE; FEMALE; HOSPITALIZATION; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INFANT; ITALY; MALE; MASS VACCINATION; MEASLES-MUMPS-RUBELLA VACCINE; RISK FACTORS; TREATMENT OUTCOME;

EID: 85015089083     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES.2016.21.24.30257     Document Type: Article

References (42)

1. Ciofi degli Atti ML, Rota MC, Mandolini D, Bella A, Gabutti G, Crovari P, et al. Assessment of varicella underreporting in Italy. Epidemiol Infect. 2002;128(3):479-84. DOI: 10.1017/S0950268802006878 PMID: 12113493
2. Gabutti G, Rota MC, Guido M, De Donno A, Bella A, Ciofi d egliAtti ML, et al, Seroepidemiology Group. The epidemiology of Varicella Zoster Virus infection in Italy. BMC Public Health. 2008;8(1):372. DOI: 10.1186/1471-2458-8-372 PMID: 18954432
3. Gabutti G, Penna C, Rossi M, Salmaso S, Rota MC, Bella A, et al, Serological Study Group. The seroepidemiology of varicella in Italy. Epidemiol Infect. 2001;126(3):433-40. DOI: 10.1017/S0950268801005398 PMID: 11467800
4. Conferenza permanente per i rapporti tra lo Stato, Regioni e le Province Autonome di Trento e Bolzano Determinazione 3 marzo 2005. Accordo ai sensi dell’art 4 del decreto legislativo 28 agosto n.281, tra il Ministro della Salute e i Presidenti delle regioni e delle province autonome, concernente il Nuovo Piano Nazionale Vaccini 2005-2007. GU n86 del 14-04-2005- Suppl ordinario n63. [Permanent Conference for relations between the State, Regions and Autonomous Provinces of Trento and Bolzano. Determination March, 3rd 2005. Agreement under Article 4 of Legislative Decree August 28th, between the Minister of Health and the Presidents of Regions and Autonomous Provinces on the New National Plan 2005-2007 Vaccines. Official Bulletin n.86 April, 4th 2005. Ordinary suppl. N.63]. Italian. Available from: http://www.salute.gov.it/imgs/C_17_pubblicazioni_543_allegato.pdf
5. D’Ancona F, Alfonsi V, Ciofidegli Atti ML. [Survey on vaccination strategies used in different Italian Regions, for the 7-valent conjugate pneumococcal, meningococcal C and varicella vaccines]. Italian. Ig Sanita Pubbl. 2006;62(5):483-92.PMID: 17206224
6. Alfonsi V, D’Ancona F, Giambi C, Nacca G, Rota MC, Regional Coordinators for Infectious Diseases and Vaccinations. Current immunization policies for pneumococcal, meningococcal C, varicella and rotavirus vaccinations in Italy. Health Policy. 2011;103(2-3):176-83. DOI: 10.1016/j.healthpol.2011.10.002 PMID: 22030308
7. Istituto Superiore di Sanità [National Institute of Health]. ICONA 2008: Indagine di COpertura vaccinale NAzionale nei bambini e negli adolescenti [ICONA 2008: Survey on national immunization coverage in children and adolescents]. 2008. Italian. Available from: http://www.iss.it/binary/publ/cont/09_29_web.pdf
8. Ministero della Salute [Ministry of Health]. Piano Nazionale Prevenzione Vaccinale (PNPV) 2012-14 [National Preventive Vaccination Plan 2012-2014]. Gazzetta Ufficiale n. 47 del 12/03/2012 (Supplemento Ordinario). Italian. Available from: http://www.salute.gov.it/imgs/C_17_pubblicazioni_1721_allegato.pdf
9. Regione Toscana [Tuscany Region]. Aggiornamento direttive regionali in materia di vaccinazioni [Updating the regional guidelines on vaccinations]. Revoca delibere n. 1249 del 24/11/2003, n.379 del 7/3/2005 e n.1060 del 10/10/2000. Modifica delibera n. 1386 del 17/12/2001. Deliberazione Giunta Regionale del 27 dicembre 2007, n. 1020, Bollettino Ufficiale Della Regione Toscana, N. 2 del 9.1.2008. Italian. Available from: http://www.fimptoscana.org/system/files/delibera%20calendario%20regionale%2027-12-2007_0.pdf
10. Centers for Disease Control and Prevention (CDC). International classification of diseases, ninth revision, clinical modification (ICD-9-CM). Atlanta, GA: CDC; 2010. Available from: http://www.cdc.gov/nchs/icd/icd9cm.htm
11. Istituto nazionale di Statistica (ISTAT)[Italian National Institute of Statistics]. Geodemo. Italian resident population (2003-2012). [Accessed January 2015]. Italian. Available from: http://demo.istat.it/
12. Bonanni P, Breuer J, Gershon A, Gershon M, Hryniewicz W, Papaevangelou V, et al. Varicella vaccination in Europe - taking the practical approach. BMC Med. 2009;7(1):26. DOI: 10.1186/1741-7015-7-26 PMID: 19476611
13. Waye A, Jacobs P, Tan B. The impact of the universal infant varicella immunization strategy on Canadian varicella-related hospitalization rates. Vaccine. 2013;31(42):4744-8. DOI: 10.1016/j.vaccine.2013.08.022 PMID: 23973325
14. Lopez AS, Zhang J, Brown C, Bialek S. Varicella-related hospitalizations in the United States, 2000-2006: the 1-dose varicella vaccinationera. Pediatrics. 2011;127(2):238-45. DOI: 10.1542/peds.2010-0962 PMID: 21199857
15. Siedler A, Dettmann M. Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany. Hum Vaccin Immunother. 2014;10(12):3594-600. DOI: 10.4161/hv.34426 PMID: 25483695
16. Giammanco G, Ciriminna S, Barberi I, Titone L, Lo Giudice M, Biasio LR. Universal varicella vaccination in the Sicilian paediatric population: rapid uptake of the vaccination programme and morbidity trends over five years. Euro Surveill. 2009;14(35):19321.PMID: 19728978
17. Cuccia M, Pollina Addario S, Cernigliaro A, Palmigiano V. Ospedalizzazione per varicella in Sicilia dopo l’introduzione della vaccinazione [Hospitalization for varicella in Sicily after the introduction of vaccination]. Bollettino Epidemiologico Nazionale (Ben) Notiziario ISS Volume 22 numero 3, Marzo 2009. Italian. Available from: http://www.epicentro.iss.it/ben/2009/marzo/1.asp
18. Baldo V, Ferro A, Napoletano G, Milani S, Bertoncello L, Baldovin T, et al. Universal varicella vaccination in the Veneto Region, Italy: launch of a programme targeting all children aged 14 months and susceptible adolescents. Euro Surveill. 2007;12(11):E071101.3.PMID: 17997908
19. Baldo V, Baldovin T, Russo F, Busana MC, Piovesan C, Bordignon G, et al. Varicella: epidemiological aspects and vaccination coverage in the Veneto Region. BMC Infect Dis. 2009;9(1):150. DOI: 10.1186/1471-2334-9-150 PMID: 19737419
20. Pozza F, Piovesan C, Russo F, Bella A, Pezzotti P, Emberti Gialloreti L. Impact of universal vaccination on the epidemiology of varicella in Veneto, Italy.Vaccine. 2011;29(51):9480-7. DOI: 10.1016/j.vaccine.2011.10.022 PMID: 22015389
21. Tafuri S, Fortunato F, Cappelli MG, Cozza V, Bechini A, Bonanni P, et al. Effectiveness of vaccination against varicella in children under 5 years in Puglia, Italy 2006-2012. Hum Vaccin Immunother. 2015;11(1):214-9. DOI: 10.4161/hv.36153 PMID:25483538
22. Bechini A, Boccalini S, Baldo V, Cocchio S, Castiglia P, Gallo T, et al. Impact of universal vaccination against varicella in Italy. Hum Vaccin Immunother. 2015;11(1):63-71. DOI: 10.4161/hv.34311 PMID: 25483517
23. Seward JF, Watson BM, Peterson CL, Mascola L, Pelosi JW, Zhang JX, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA. 2002;287(5):606-11. DOI: 10.1001/jama.287.5.606 PMID: 11829699
24. Marin M, Güris D, Chaves SS, Schmid S, Seward JF, Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC). Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(4):1-40. PMID: 17585291
25. Centers for Disease Control and Prevention (CDC). Evolution of varicella surveillance--selected states, 2000-2010. MMWR Morb Mortal Wkly Rep. 2012;61(32):609-12.PMID: 22895384
26. Chaves SS, Lopez AS, Watson TL, Civen R, Watson B, Mascola L, et al. Varicella in infants after implementation of the US varicella vaccination program. Pediatrics. 2011;128(6):1071-7. DOI: 10.1542/peds.2011-0017 PMID: 22123875
27. Kattan JA, Sosa LE, Bohnwagner HD, Hadler JL. Impact of 2-dose vaccination on varicella epidemiology: Connecticut--2005-2008. J Infect Dis. 2011;203(4):509-12. DOI: 10.1093/infdis/jiq081 PMID: 21199882
28. Marin M, Meissner HC, Seward JF. Varicella prevention in the United States: a review of successes and challenges. Pediatrics. 2008;122(3):e744-51. DOI: 10.1542/peds.2008-0567 PMID: 18762511
29. Lopez AS, Zhang J, Brown C, Bialek S. Varicella-related hospitalizations in the United States, 2000-2006: the 1-dose varicella vaccinationera. Pediatrics. 2011;127(2):238-45. DOI: 10.1542/peds.2010-0962 PMID: 21199857
30. Zhou F, Harpaz R, Jumaan AO, Winston CA, Shefer A. Impact of varicella vaccination on health care utilization. JAMA. 2005;294(7):797-802. DOI: 10.1001/jama.294.7.797 PMID:16106004
31. Shah SS, Wood SM, Luan X, Ratner AJ. Decline in varicellarelated ambulatory visits and hospitalizations in the United States since routine immunization against varicella. Pediatr Infect Dis J. 2010;29(3):199-204. DOI: 10.1097/INF.0b013e3181bbf2a0 PMID: 19949362
32. Davis MM, Patel MS, Gebremariam A. Decline in varicellarelated hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States. Pediatrics. 2004;114(3):786-92. DOI: 10.1542/peds.2004-0012 PMID: 15342855
33. Galil K, Brown C, Lin F, Seward J. Hospitalizations for varicellain the United States, 1988 to 1999. Pediatr Infect Dis J. 2002;21(10):931-5. DOI: 10.1097/00006454-200210000-00009 PMID: 12394815
34. Ratner AJ. Varicella-related hospitalizations in the vaccine era. Pediatr Infect Dis J. 2002;21(10):927-31. DOI: 10.1097/00006454-200210000-00008 PMID: 12394814
35. Reynolds MA, Watson BM, Plott-Adams KK, Jumaan AO, Galil K, Maupin TJ, et al. Epidemiology of varicella hospitalizations in the United States, 1995-2005. J Infect Dis. 2008;197(2);S120-6. DOI: 10.1086/522146 PMID: 18419384
36. Siedler A, Arndt U. Impact of the routine varicella vaccination programme on varicella epidemiology in Germany. Euro Surveill. 2010;15(13):19530.PMID: 20394710
37. Knuf M, Neiss A, Wutzler P. Impact of universal varicella vaccination in Germany: an epidemiological and economic analysis. Klin Padiatr. 2006;218(4):203-12. German. DOI: 10.1055/s-2005-836610 PMID: 16819701
38. Spackova M, Muehlen M, Siedler A. Complications of varicella after implementation of routine childhood varicella vaccination in Germany. Pediatr Infect Dis J. 2010;29(9):884-6. DOI: 10.1097/INF.0b013e3181e2817f PMID: 20442685
39. Azzari C, Massai C, Poggiolesi C, Indolfi G, Spagnolo G, De Luca M, et al. Cost of varicella-related hospitalisations in an Italian paediatric hospital: comparison with possible vaccination expenses. Curr Med Res Opin. 2007;23(12):2945-54. DOI: 10.1185/030079907X242610 PMID: 17937842
40. Thiry N, Beutels P, Tancredi F, Romanò L, Zanetti A, Bonanni P, et al. An economic evaluation of varicella vaccination in Italian adolescents. Vaccine. 2004;22(27):3546-62. DOI: 10.1016/j.vaccine.2004.03.043 PMID: 15315834
41. Coudeville L, Brunot A, Giaquinto C, Lucioni C, Dervaux B. Varicella vaccination in Italy: an economic evaluation of different scenarios. Pharmacoeconomics. 2004;22(13):839-55. DOI: 10.2165/00019053-200422130-00003 PMID: 15329030
42. Bonanni P, Boccalini S, Bechini A, Banz K. Economic evaluation of varicella vaccination in Italian children and adolescents according to different intervention strategies: the burden of uncomplicated hospitalised cases. Vaccine. 2008;26(44):5619-26. DOI: 10.1016/j.vaccine.2008.07.096 PMID: 18723062